China Modern Dairy Holdings Issuer Summary

Report date: 2026-05-15
Issuer: China Modern Dairy Holdings Ltd.
Ticker / bond reference: CNMDHL / HKEX 01117 / U.S.$350,000,000 4.875% Sustainability Bonds due 2030
Primary source cut-off: 2026-05-15

1. Business Snapshot and Recent Developments

China Modern Dairy Holdings Ltd. (“Modern Dairy” or “CNMDHL”) is a Hong Kong-listed dairy farming group operating large-scale dairy farms, raw milk production, feed and farm supplies, breeding-related products, and digital dairy farming platforms, primarily in mainland China. Its shares are listed on HKEX, and in July 2025 it issued U.S. dollar-denominated 2030 sustainability bonds with China Modern Dairy Holdings Ltd. as the issuer. For bond investors, the credit is not simply a branded food company, but an upstream dairy farming credit exposed to the raw milk price cycle, fair value changes in dairy cattle assets, feed costs, offtake to a key customer, and structural subordination at the Cayman holding-company bond level.

The FY2025 profile can be summarised as one in which scale and cash earnings capacity were maintained, while accounting earnings were heavily pressured by fair value losses on dairy cows. According to the FY2025 results announcement, 2025 revenue was RMB12.601bn, down 4.9% year on year; gross profit was RMB3.454bn, broadly flat; and Cash EBITDA was RMB3.063bn, up 2.6%. By contrast, fair value losses on dairy cows widened to RMB3.108bn, and loss attributable to shareholders was RMB1.129bn. The key point is that judging the company solely by its accounting loss would overstate the weakness, while looking only at Cash EBITDA would understate the raw milk cycle and the decline in asset values. Credit analysis needs to assess both cash-based repayment capacity and the deterioration in dairy cattle values, raw milk prices, and capital structure.

On the operating side, the number of dairy cows at end-2025 was 456,945 head, down 7.0% from 491,169 head at end-2024. This was not simply a contraction, but also reflected the company’s optimisation of herd composition and an increase in the proportion of milkable cows to 58.2%. Raw milk sales volume rose 8.5% to 3.139 million tonnes, and average milk yield improved slightly to 12.9 tonnes per head per year. Volumes and productivity improved, but raw milk ASP fell 7.7%, from RMB3,613/tonne to RMB3,335/tonne. In other words, the 2025 credit story should be read as one in which the company tried to absorb price declines through volume and efficiency, but industry-wide price weakness and dairy cattle valuation losses continued to pressure earnings.

China’s raw milk market is not an idiosyncratic issue for the company, but is in an industry-wide supply-demand adjustment phase. The company’s FY2025 industry review states that consumer demand recovery remained weak and raw milk prices declined for a fourth consecutive year, while national raw milk production still increased slightly despite a decline in dairy cattle numbers, as milk yield per cow improved. As long as supply-demand slack remains, Modern Dairy’s scale, cost control, and offtake to Mengniu are important defensive lines, but they do not fully restore pricing power.

The relationship with Mengniu is central to CNMDHL’s credit profile. As of end-2025, China Mengniu Dairy Co., Ltd. and its wholly owned subsidiary held 56.36% of Modern Dairy’s issued shares. Mengniu is the controlling shareholder, a major customer, and a provider of related financing facilities. In FY2025, revenue from Customer A, a customer accounting for more than 10% of revenue, was RMB9.195bn, representing approximately 73.0% of consolidated revenue. The Offering Circular states that Modern Dairy is Mengniu’s largest raw milk supplier, and that the offtake agreement that began in 2008 was extended in 2018 for 10 years, running until October 2028. This agreement supports a floor for raw milk sales volume and cash flow, but Mengniu is not a bond guarantor, so business stability support must be distinguished from legal creditor protection.

As a capital markets event, the company issued U.S.$350m 4.875% Sustainability Bonds due 2030 in July 2025. This is a positive indication of its access to the offshore market and contributed to capital structure optimisation in 2025. At the same time, FY2025 finance costs were RMB637.2m, up 20.5% year on year, and the company explained that part of the increase was due to additional interest from the new U.S. dollar bond issuance. The extension of the refinancing maturity profile is positive, but interest expense and the presence of foreign-currency debt become fixed cash-flow burdens in a weak raw milk price environment.

The most recent M&A event concerns China Shengmu Organic Milk Limited (“Shengmu”). The transaction was announced in October 2025, a circular on the major and connected transaction was published in December 2025, and on 7 May 2026, satisfaction of certain conditions was achieved through SAMR antitrust clearance. The 7 May announcement stated that SPA Completion was expected to take place on or before 22 May 2026, but as of the 15 May 2026 report date, no announcement confirming completion itself had been identified in the reviewed materials. This report therefore treats Shengmu not as completed consolidated results, but as an event that may shortly give rise to consolidation, a mandatory offer, and funding requirements.

In summary, CNMDHL is an issuer directly exposed to weakness in China’s raw milk market, while also having scale, the Mengniu relationship, cash earnings capacity, and access to bank and bond markets. The credit analysis focuses on how much Cash EBITDA and operating cash flow remain if raw milk prices weaken further, how far Mengniu offtake provides a defensive line in both volume and price, how much liquidity the funding burden of the Shengmu acquisition consumes, and the extent to which the Cayman issuer’s U.S. dollar bonds can access cash flow from the Chinese operating subsidiaries.

2. Industry Position and Franchise Strength

Modern Dairy’s business base is supported by its scale as a large-scale dairy farming company in China, milk yield, production management, and long-term relationship with Mengniu. The FY2025 results announcement describes the company as a leading enterprise in China’s dairy cattle farming and raw milk production industry, and states that it has built a value chain centred on raw milk and covering feed, breeding, and platform services. This report has not recalculated a precise market share ranking using external statistics, but 456,945 dairy cows, raw milk sales volume of 3.139 million tonnes, and average milk yield of 12.9 tonnes per head per year are sufficient, for credit analysis purposes, to treat the company as at least a large-scale top-tier player.

The credit significance of large-scale dairy farming is not simply that revenue is large. In dairy farming, profitability is determined by biological assets, feed, veterinary care and disease prevention, labour, land and facilities, milking equipment, logistics, and distance to customer plants. Compared with small-scale farms, scale benefits are more likely to arise in feed procurement, farm management, genetic breeding, disease control, quality control, digital monitoring, and financing. Modern Dairy states that, through improvements in feed formulation, adjustments to feed mix, herd health management, and higher milk yield per milkable cow, it reduced raw milk unit cost to RMB2.32/kg and average feed cost to RMB1.77/kg in 2025. In an environment of falling raw milk ASP, such unit cost reductions are an important defensive line for credit quality.

However, economies of scale do not eliminate the raw milk price cycle. In 2025, raw milk ASP was RMB3.33/kg, down from RMB3.61/kg in 2024. The company attributes the decline in market prices mainly to oversupply of raw milk in China. Raw milk is not a branded consumer product, but a raw material sold to downstream dairy product manufacturers, so the company does not have the same pricing pass-through power as a consumer-facing branded company. There can be premiums based on quality, distance, volume, and stability of supply, but if the market price itself declines, sales unit prices and dairy cattle valuations come under pressure. Therefore, Modern Dairy’s franchise is strong, but its pricing power is limited.

Industry supply-demand adjustment has two-sided implications for credit quality. If dairy cattle numbers are rationalised and small and medium-sized farms exit, supply may eventually tighten and support a bottoming of raw milk prices. The company also refers to the decline in dairy cattle numbers and market clearing in its 2025 industry review. On the other hand, when national raw milk production is still increasing because of improved milk yield per cow, a decline in cattle numbers alone does not prove supply-demand improvement. Modern Dairy itself is also pursuing higher milk yields, so its efficiency gains are positive for the company but can support overall industry supply.

The relationship with Mengniu differentiates the company’s business base from other independent dairy farming companies. Under the offtake agreement, Mengniu is required to procure 70% of the raw milk produced by Modern Dairy, while Modern Dairy also has flexibility to sell part of its production to third parties. According to the Offering Circular, Mengniu procured an average of 92.7% of Modern Dairy’s raw milk from 2022 to 2024, above the minimum level. This relationship reduces volume risk, supports the credit quality of receivables collection, and facilitates coordination on quality standards and logistics. The fact that approximately 73% of 2025 revenue was concentrated with a major customer is a risk, but because that counterparty is the controlling shareholder and a major Chinese dairy manufacturer, the credit implications are more complex than simple customer concentration.

Mengniu dependence is also a weakness. First, because the company’s customer and shareholder overlap, related-party transactions, price setting, financing facilities, and capital policy need to be monitored separately. Second, if Mengniu’s downstream demand or competitiveness in the dairy product market weakens, the effects would flow through to Modern Dairy’s sales volume, pricing, and collection. Third, although Mengniu is a shareholder, customer, and financing counterparty, it is not a guarantor of the 2030 U.S. dollar bonds. The relationship with Mengniu mitigates business risk, but it is not a legal payment guarantee.

The Shengmu transaction has positive potential in terms of franchise expansion. In the Prospects section of its FY2025 results, the company states that successful consolidation of China Shengmu Organic Milk Limited could expand business scale, leverage economies of scale, and strengthen the product mix with higher average selling prices. Shengmu has a stronger organic milk profile and could improve mix relative to Modern Dairy’s regular raw milk business. However, synergies should not be incorporated into credit quality before completion of the transaction; the acquisition consideration, completion or non-completion of the mandatory offer, post-consolidation debt, minority interests, and integration costs should be confirmed first.

Another element supporting the company’s business base is the internalisation of farm management, breeding, and feed. The FY2025 results refer to breeding businesses such as Meng Yuan Genetics, Modern Grassland, the Aiyangniu platform, and the feed and farm supplies business. These are meaningful less as large standalone external revenue generators than as infrastructure supporting the cost, quality, health management, and data utilisation of the raw milk business. In a dairy farming credit, such production management capabilities influence resilience to accidents, disease, and feed price volatility, so they are important credit factors even though they are not easily visible in the financial statements.

Overall, Modern Dairy’s franchise is strong for an upstream dairy farming company. Scale, milk yield, cost management, the Mengniu relationship, and quality control support credit quality. However, because the core business is raw milk, the company is not free from the price cycle, dairy cattle valuation, feed, disease, or customer concentration. Rather than expecting the stable margins of a downstream branded food company, it is more appropriate to view the issuer as a credit with strong offtake and cash earnings capacity, but significant volatility from raw milk prices and biological asset valuation.

3. Segment Assessment

Modern Dairy’s disclosed reporting segments are Raw milk business and Integrated dairy farming solutions business. The Raw milk business covers the farming and breeding of dairy cows and the production and sale of raw milk. The Integrated dairy farming solutions business includes feed and farm supplies, breeding products, and digital platform services. The core of credit quality is clearly the Raw milk business, while Integrated dairy farming solutions should be viewed not only through its external revenue but also as a complementary business supporting the cost, quality, and supply chain of the raw milk business.

The Raw milk business is the core segment, accounting for approximately 83% of revenue. Raw milk sales volume rose to 3.139 million tonnes in 2025, while ASP fell 7.7%. Revenue remained broadly flat because volume growth absorbed the price decline. The maintenance of gross margin at 31.2% is credit positive as evidence of cost management. Unit cost fell from RMB2.53/kg to RMB2.32/kg, and average feed cost also declined from RMB1.95/kg to RMB1.77/kg, allowing the company to absorb part of the price decline.

However, the Raw milk business segment result remained in loss. This is because the segment result reflects not only ordinary raw milk production and sales, but also fair value losses on dairy cows, finance costs, and other segment expenses. In dairy company accounting, fair value recognition at the time of raw milk production, dairy cattle asset valuations, cull cow values, and assumptions on future raw milk prices have a large impact on profit or loss. The maintenance of gross profit indicates cash earnings resilience, but the large fair value loss on dairy cows indicates downward revision pressure on future cash flow expectations and asset values. The Raw milk business is therefore a segment that holds up at the gross profit level, but has earnings that can swing materially through asset valuation.

The Integrated dairy farming solutions business is smaller in terms of external revenue, but supports production efficiency in the raw milk business and provides services to external farms. External revenue in 2025 was RMB2.135bn, down 23.8%. The company attributes this to weak market demand and stricter customer selection for operational risk management. From a credit perspective, the revenue contraction itself is negative, but it is more rational to protect collection and margins through customer selection than to expand sales to lower-quality customers and increase receivables risk. The improvement in gross margin from 6.9% to 9.0% provides some support for this assessment.

At the same time, the solutions business should not be overestimated as a major profit source. Its 2025 segment loss was RMB35m, small compared with the loss in the Raw milk business. Its value lies more in supporting the raw milk business through feed and farm supplies, breeding, data, and quality control than in generating external profit. If weakness in raw milk prices persists and independent farms’ investment appetite or demand for feed and supplies weakens, external growth in the solutions business may slow.

Inter-segment transactions are also important. Integrated dairy farming solutions recorded RMB3.492bn of inter-segment sales in 2025, which are eliminated on consolidation. This means the business is deeply embedded in the group’s internal raw milk production supply chain, not merely an external sales business. While there are internal functions not visible in headline consolidated revenue, internal transaction pricing and eliminations need to be considered when reading segment profitability on a standalone basis.

In summary, the Raw milk business is the core cash-generating business supported by scale, Mengniu offtake, sales volume, and cost management, but it is highly sensitive to raw milk prices and dairy cattle valuation losses. Integrated dairy farming solutions is smaller and variable in revenue terms, but provides complementary functions supporting cost, quality, and digitalisation in the raw milk business. If Shengmu is consolidated in the future, segment composition and the organic milk mix may change, but this report does not yet treat it as post-completion results.

4. Financial Profile and Analysis

Modern Dairy’s financial profile needs to be read by separating accounting profit or loss, cash earnings, and capital structure. In 2025, the headline items were revenue decline, accounting loss, and wider fair value losses on dairy cows, but Cash EBITDA and operating cash flow remained positive, and gross margin improved. At the same time, net gearing increased and short-term interest-bearing debt also rose. The financial profile should therefore be read as one in which the company is still holding up on a cash basis, but pressure on leverage and liquidity would intensify if weak raw milk prices continue.

Looking at revenue and gross profit, the company absorbed a meaningful portion of the price decline through volume and cost in 2025. Revenue declined 4.9%, but gross profit was broadly flat and gross margin rose to 27.4%. In the raw milk business, gross margin remained at 31.2% despite the decline in raw milk ASP. This indicates the effects of lower feed prices, improved formulation, higher milk yield, and herd management. From a credit perspective, this cost response is important. If gross margin had also fallen sharply in a weak raw milk price environment, the company’s credit outlook would be much weaker.

However, maintaining gross margin is not enough to remove concern. The company recorded a substantial accounting loss because fair value losses on dairy cows reached RMB3.108bn. Biological asset valuation has a strong non-cash component, but it should not be dismissed as mere accounting noise. Dairy cattle values depend on assumptions such as future raw milk prices, feed costs, milk yield, cull cow prices, and discount rates. A large fair value loss may reflect deterioration in the market environment for future earnings capacity, asset values, and collateral capacity. Bond investors should value positive Cash EBITDA, while also taking seriously the fact that dairy cattle valuation losses erode equity and push up net gearing.

Cash EBITDA was RMB3.063bn, up 2.6%. The increase in Cash EBITDA despite lower revenue indicates operating resilience on a cash basis. Cash EBITDA margin also improved from 22.5% to 24.3%. Operating cash flow was RMB2.502bn, which the company describes as up 4.1% year on year. This shows that despite the accounting loss, the company is generating cash to support debt interest, working capital, and a certain level of investment. The most important financial support for credit quality is this cash earnings capacity.

Leverage and liquidity, however, are not loose. Company-defined net borrowings were RMB11.355bn, slightly up from RMB10.795bn, and net gearing rose to 115.7%. Equity declined due to the loss attributable to shareholders and other comprehensive income effects, while borrowings increased, including from the 2030 U.S. dollar bond issuance. The company explains that it increased borrowings to use domestic and overseas financing market opportunities, optimise its debt structure, and reduce overall financing costs. For investors, however, the benefit of lower funding cost needs to be assessed alongside the increase in total debt, interest expense, and foreign-currency risk.

On short-term liquidity, current assets were RMB11.581bn and current liabilities were RMB12.048bn at end-2025, resulting in net current liabilities of RMB467m. The net current liability position narrowed from RMB551m at end-2024, but still indicates a need for short-term funding management. Current interest-bearing borrowings excluding leases, based on our calculation, were RMB7.136bn, a large increase from RMB2.963bn at end-2024. That said, cash and deposit assets increased to RMB7.909bn, and undrawn facilities were RMB7.420bn. The company prepares its financial statements on a going-concern basis after considering expected operating cash inflows and undrawn facilities over the next 12 months.

The composition of undrawn facilities also needs to be examined. The FY2025 results state that of the RMB7.420bn in undrawn facilities, RMB2.386bn had maturities beyond one year, RMB1.000bn was from Mengniu’s subsidiary Inner Mongolia Mengniu, and the remainder was from banks. This is positive as liquidity support, but related-party facilities and bank facilities should not be treated as identical funding sources. The Mengniu facility indicates the strength of the relationship, but it is not a bond guarantee, and its borrowing terms and continuity may depend on the transaction relationship, related-party approvals, and market conditions.

Finance costs are increasing. Of the RMB637m in 2025 finance costs, RMB545m related to interest-bearing borrowings and RMB93m to lease liabilities. Finance costs increased 20.5% year on year, and the company identified the additional interest from the U.S. dollar bond issuance as one of the main drivers. The level of finance costs relative to Cash EBITDA is still absorbable, but if raw milk prices fall further and Cash EBITDA contracts, interest coverage could deteriorate quickly. From 2026 onward, semi-annual coupon payments on the 2030 bond, domestic debt, bank borrowings, and Shengmu-related funding needs will overlap, so interest payment and refinancing capacity need to be monitored.

On collateral and assets, RMB1.101bn of biological assets and RMB15.8m of property were pledged for borrowings at end-2025. Pledges over buildings and equipment and receivables were limited, and no material contingent liabilities were disclosed. The limited amount of pledged assets may indicate some collateral capacity, but for bondholders, the recovery ranking of unsecured bonds needs to be distinguished from secured borrowings at the operating subsidiary level.

The financial conclusion is that Modern Dairy reported an accounting loss in 2025, but retained cash earnings and operating cash flow. This does not indicate an immediate liquidity crisis. At the same time, higher net gearing, increased short-term debt, higher finance costs, and equity erosion from fair value losses on dairy cows are constraints on credit quality. If raw milk prices stabilise in 2026, the company’s cash earnings are more likely to be maintained. If price weakness persists and the funding burden of the Shengmu transaction overlaps, reliance on cash balances and financing facilities will increase.

5. Structural Considerations for Bondholders

The first point to confirm when analysing CNMDHL’s U.S. dollar bonds is that the bond issuer is China Modern Dairy Holdings Ltd., an investment holding company incorporated in the Cayman Islands. According to the July 2025 Offering Circular, the U.S.$350m 4.875% Sustainability Bonds due 2030 were issued by China Modern Dairy Holdings Ltd., and the Trust Deed was entered into between the company and the Trustee. The bonds constitute direct, unconditional, unsubordinated, and unsecured obligations of the issuer, ranking at least pari passu with all other present and future unsecured and unsubordinated obligations of the issuer.

However, this is a ranking at the issuer level and does not mean that the bonds rank pari passu with debt at the Chinese operating subsidiaries. The FY2025 results state that the company’s principal activity at the parent level is investment holding and that operations are conducted through subsidiaries. Raw milk production, farms, dairy cows, receivables, bank borrowings, domestic debt, and the Mengniu offtake are mainly located at the Chinese operating subsidiary level. No explicit subsidiary guarantors for the U.S. dollar bonds have been identified, so bondholders depend on the issuer’s ability to receive dividends, loan repayments, or other intra-group fund transfers from subsidiaries. This is the core of structural subordination.

The key terms of the 2030 bonds are as follows.

The sustainability bond label should also be treated as limited for credit analysis purposes. The Offering Circular explains that although the bonds are issued as sustainability bonds under the Sustainable Finance Framework, the performance of the bonds is not linked to the performance of the Eligible Assets or sustainability targets, and there is no priority claim over Eligible Assets. Therefore, the sustainability label is relevant to use of proceeds and investor demand, but it is not a legal credit enhancement for principal or interest payments.

The relationship with Mengniu needs to be treated carefully from a structural perspective. Mengniu is the controlling shareholder, major customer, and provider of related financing facilities, and it supports business cash flow through offtake. However, it is not a guarantor of the 2030 bonds. The RMB1.000bn undrawn facility from a Mengniu subsidiary is part of liquidity, but it does not guarantee payment of bond principal or interest. Investors should assess the Mengniu relationship as support for business and funding access, while clearly distinguishing it from a legal parent guarantee.

Structural subordination to Chinese subsidiaries becomes important under stress. In normal conditions, the Chinese operating subsidiaries can generate operating cash flow, refinance bank borrowings and domestic debt, and upstream funds to the parent when needed. However, if weak raw milk prices, dairy cattle valuation losses, pledges for bank borrowings, domestic debt maturities, and Shengmu-related funding needs overlap, cash may remain within subsidiaries and upstreaming to the Cayman issuer may be constrained. Recovery on the unsecured U.S. dollar bonds depends not only on consolidated financial metrics, but also on which legal entities hold cash and which creditors have prior access.

The Shengmu transaction may also complicate the structure. If the transaction completes, Modern Dairy’s group perimeter, minority interests, debt, related-party transactions, and cash outflow related to the mandatory offer may change. Before completion, pro forma leverage ratios and cash balances should not be stated definitively. Investors need to confirm the SPA Completion announcement, Composite Document, offer results, funding arrangements, and post-consolidation debt, collateral, and minority shareholder structure.

6. Capital Structure, Liquidity and Funding

Modern Dairy’s capital structure consists of bank borrowings, other borrowings, long-term bonds, short-term debt, lease liabilities, and related-party financing facilities. At end-2025, interest-bearing debt excluding leases based on our calculation was RMB19.264bn, up from RMB14.463bn at end-2024. The main drivers of the increase were the issuance of the 2030 U.S. dollar bonds and the use of domestic and overseas financing. Company-defined net borrowings were RMB11.355bn, and net gearing was 115.7%.

Cash and deposit assets were RMB7.909bn, up from RMB3.668bn at end-2024. This reflects funding inflows from the 2030 bond issuance and the use of financing markets. On the surface, cash and deposit assets slightly exceeded current interest-bearing borrowings of RMB7.136bn. However, not all cash can necessarily be freely used for repayment of the U.S. dollar bonds; working capital at operating subsidiaries, pledged or restricted deposits, domestic debt maturities, and funding for the Shengmu transaction need to be considered.

A positive liquidity factor is RMB7.420bn of undrawn facilities. Of this, RMB2.386bn had maturities of more than one year, RMB1.000bn was from Inner Mongolia Mengniu, and the remainder was from banks. In addition, operating cash flow was positive at RMB2.502bn in 2025. Taken together, the company is not a credit that repays short-term debt simply with cash on hand, but one that refinances using a combination of operating cash flow, bank facilities, related-party facilities, and market funding.

The constraints are the increase in short-term debt and finance costs. Current interest-bearing borrowings at end-2025 consisted of bank borrowings of RMB2.189bn, other borrowings of RMB1.643bn, current long-term bonds of RMB3.100bn, and short-term bonds of RMB204m. If lease liabilities are added, short-term fixed obligations are larger. Finance costs in 2025 were RMB637m, of which RMB545m related to interest-bearing borrowings. With Cash EBITDA of RMB3.063bn, the company has interest absorption capacity in normal conditions, but if raw milk ASP falls further and Cash EBITDA contracts materially, the fixed nature of finance costs will become more visible.

Foreign-currency risk also remains. The company conducts most of its business in mainland China and its functional currency is RMB, while the 2030 bonds are denominated in U.S. dollars. The FY2025 results state that exchange-rate movements between RMB and USD are the main foreign-currency risk, and that the company uses instruments such as foreign-currency options and cross-currency swaps as needed. In 2025, fair value gains or losses on derivatives and foreign-exchange gains or losses also arose. Payment of principal and interest on the U.S. dollar bonds requires conversion of RMB business cash flow into U.S. dollar funding, making FX, capital controls, and remittance mechanics relevant under stress.

The presence of secured borrowings should also be noted. At end-2025, RMB1.101bn of biological assets and RMB15.8m of property were pledged for borrowings. The amount is limited relative to total assets, but if dairy cattle values decline in a weak raw milk price environment, collateral capacity or bank borrowing terms may change. The unsecured U.S. dollar bonds rank pari passu at the issuer level, but can be effectively subordinated to secured debt and operating subsidiary-level debt.

Funding access was demonstrated in 2025. The U.S. dollar bond issuance, domestic short-term commercial paper and medium-term notes, bank facilities, and Mengniu-related facilities show that the company has multiple funding sources. However, funding access is also an outcome of credit conditions. If weak raw milk prices persist, Cash EBITDA weakens, and net gearing rises further, refinancing terms are likely to deteriorate. In particular, because this report has not independently confirmed current issuer or bond ratings or market spreads, investors should separately check actual bond pricing and liquidity.

Post-Shengmu liquidity remains uncertain. The 7 May 2026 announcement stated that certain conditions had been satisfied through SAMR clearance and that SPA Completion was expected to take place on or before 22 May 2026. The offer is conditional on SPA Completion, and the amount of cash outflow and consolidation perimeter will differ depending on completion and the offer result. Modern Dairy’s cash balance and facilities indicate some headroom, but post-completion pro forma debt, cash, minority interests, and short-term maturities need to be reconfirmed after the completion announcement and offer results.

7. Rating Agency View

The rating-related information confirmed in this report is that the July 2025 Offering Circular stated that the 2030 bonds were expected to be assigned a BBB rating by S&P. This was the expected issue rating at issuance and is not an independent confirmation of the current issuer rating or current bond rating. The Offering Circular itself also cautions that ratings are not recommendations to buy or sell and may be suspended, downgraded, or withdrawn.

This point matters. Modern Dairy has business scale, the Mengniu relationship, cash earnings capacity, and market access, while also facing an accounting loss, fair value losses on dairy cows, weak raw milk prices, higher net gearing, and a Cayman issuer structure. It would be insufficient to mechanically treat the company’s current credit quality as investment grade solely because of the BBB expected issue rating at issuance. Conversely, it would also be too crude to classify the issuer as high risk based only on the accounting loss. Ratings are a useful reference point, but investors should confirm in the latest rating action how far the rating agency reflects the Mengniu relationship, industry cycle, liquidity, and bond structure in its assessment.

This report has not independently confirmed the latest S&P rating action text, current outlook, current rating on the 2030 bonds, or secondary-market spread. Therefore, the Rating Agency View section is limited to stating the expected issue rating at issuance as a fact. For investment decisions, investors need to separately confirm the latest rating report, rating definitions, rating triggers, peer comparisons, and bond prices.

8. Credit Positioning

CNMDHL’s credit position combines a strong business base with cyclical pressure. Strengths include the scale of raw milk production, offtake with Mengniu, the relationship with the controlling shareholder, Cash EBITDA, operating cash flow, and access to bank and bond markets. Constraints include weak raw milk prices, fair value losses on dairy cows, accounting losses, higher net gearing, increased short-term debt, structural subordination of the Cayman holding-company bonds, and the uncertain funding burden of the Shengmu transaction.

Compared with downstream dairy manufacturers or branded food companies, the company has lower earnings stability. Raw milk is not a consumer brand, but a raw material for downstream manufacturers, so pricing is more strongly influenced by industry supply and demand. Modern Dairy can support volume and sales channels through quality, scale, and the Mengniu contract, but it cannot move raw milk market prices by itself. In this respect, its business risk is higher than that of a typical food consumer goods company.

Compared with independent small and medium-sized dairy farming companies, however, Modern Dairy is relatively strong. It has customer quality, financing facilities, farm management, unit cost, milk yield, and capital markets access. In a weak raw milk price environment, smaller farms have less funding flexibility and less room to cut costs, making them more exposed to industry clearing. While Modern Dairy is subject to the same price weakness, scale, Mengniu offtake, funding access, and maintained Cash EBITDA make it more likely to be positioned among the relative survivors.

For bond investors, the core point is that the company is a “strong but not stable” credit. In normal conditions, sales to Mengniu and Cash EBITDA can support debt. However, if raw milk prices fall further, dairy cattle valuation losses erode equity, Shengmu acquisition funding overlaps, and bank refinancing tightens, credit metrics could deteriorate quickly. Therefore, even though the credit has an investment-grade-like external profile, it should be monitored frequently.

Assessing relative value requires current bond prices, spreads, ratings, comparisons with Chinese food and dairy peers, and comparisons with Mengniu-related credits. This report has not checked market prices, so it does not opine on investment attractiveness. From a credit fundamentals perspective, the key drivers of relative positioning will be whether the company can maintain Cash EBITDA and operating cash flow in a weak price environment, how much liquidity remains after the Shengmu transaction, and how the Mengniu relationship is renewed beyond 2028.

9. Key Credit Strengths and Constraints

The first key credit strength is scale and productivity. The 456,945 dairy cows at end-2025, raw milk sales volume of 3.139 million tonnes, and average milk yield of 12.9 tonnes per head per year demonstrate the production base of a large-scale dairy farming company. Scale supports feed procurement, farm management, quality control, disease control, digitalisation, and bank and market access, increasing resilience compared with small and medium-sized farms in a weak raw milk price environment.

The second strength is the relationship with Mengniu. The company has multiple relationships with Mengniu as controlling shareholder, major customer, offtake counterparty, and provider of financing facilities, supporting volume, collection, and funding access. The fact that approximately 73% of 2025 revenue was concentrated with a major customer is a risk, but the fact that the counterparty is the Mengniu group and that there is an offtake agreement through 2028 provides a form of credit support different from ordinary customer concentration.

The third strength is cash earnings capacity. The company reported an accounting loss in 2025, but Cash EBITDA was positive at RMB3.063bn and operating cash flow was positive at RMB2.502bn. Gross margin also improved, and raw milk business gross margin was maintained at 31.2%. This shows that the company did not immediately fall into a cash loss position despite price declines.

The fourth strength is funding access. The U.S.$350m 2030 bond issuance in 2025, bank facilities, domestic debt, and Mengniu-related facilities show that the company has multiple funding sources. Cash and deposit assets and undrawn facilities at end-2025 provide room to manage short-term debt.

The first key constraint is the raw milk price cycle. Raw milk ASP fell 7.7% year on year in 2025, and the company cited oversupply of raw milk in China as the reason. Volume growth and cost reductions protected gross profit, but if prices fall further, the room for defence will narrow.

The second constraint is fair value losses on dairy cows and pressure on equity. The fair value loss on dairy cows was RMB3.108bn in 2025, and loss attributable to shareholders was RMB1.129bn. Although the non-cash component is large, the loss reduces equity and raises net gearing, constraining debt capacity.

The third constraint is leverage and liquidity. Net gearing rose to 115.7%, and current interest-bearing borrowings also increased. Cash and undrawn facilities are available, but if weak raw milk prices, the Shengmu transaction, and higher finance costs overlap, liquidity headroom could be consumed quickly.

The fourth constraint is structural subordination. The U.S. dollar bonds are unsecured obligations issued by a Cayman holding company, and no subsidiary guarantee has been identified. Because operating cash flow and assets are mainly located in Chinese subsidiaries, bank debt, domestic debt, secured debt, and working capital may absorb cash first under stress.

The fifth constraint is uncertainty around the Shengmu transaction. If completed, the transaction could provide positive potential in terms of scale, organic milk mix, and synergies. At the same time, acquisition funding, the mandatory offer, integration, consolidated debt, and minority shareholder structure will affect liquidity and leverage. Credit improvement should not be taken in advance before post-completion pro forma metrics are confirmed.

10. Downside Scenarios and Monitoring Triggers

The first downside is a further decline in raw milk prices. The metrics to monitor are raw milk ASP, sales volume, raw milk unit cost, feed cost, Raw milk business gross margin, and Cash EBITDA. In 2025, the company maintained gross margin despite a 7.7% decline in ASP, but if prices fall further and feed prices stop declining, gross margin and Cash EBITDA could deteriorate simultaneously.

The second downside is continued fair value losses on dairy cows. If large fair value losses persist, they will affect not only accounting profit but also equity, net gearing, collateral value, and banks’ risk perception. Metrics to monitor include fair value losses on dairy cows, biological asset balance, proportion of milkable cows, cull cow prices, average milk yield, and NAV per share.

The third downside is weakening of the Mengniu relationship. The offtake agreement runs until October 2028, but renewal terms, price calculation, purchase volume, related financing facilities, and revenue concentration need to be monitored. A sharp decline in sales to Mengniu, deterioration in payment terms, reduction in financing facilities, or uncertainty over contract renewal could materially weaken the credit view.

The fourth downside is the funding burden of the Shengmu transaction. SPA Completion, the Composite Document, offer results, acquisition consideration, funding sources, post-consolidation cash, post-consolidation debt, and minority interests should be confirmed. Even if the acquisition is strategically reasonable, a large cash outlay and higher short-term debt in a weak raw milk price environment could be negative for near-term credit quality.

The fifth downside is a deterioration in the refinancing environment. Metrics to monitor include current interest-bearing borrowings, undrawn facilities, bank facility maturities, domestic debt issuance, U.S. dollar bond prices, ratings, finance costs, and hedging status. Liquidity at end-2025 appears manageable, but short-term debt is significant and finance costs have increased, so higher refinancing costs would erode Cash EBITDA.

The sixth downside is disease, food safety, or ESG incidents. In large-scale dairy farming, infectious disease, feed contamination, water resources, manure treatment, animal welfare, labour, and safety incidents can lead to operating disruption or higher costs. Modern Dairy emphasises quality and digital management, but the impact of an incident could extend beyond a single farm to Mengniu supply, brand, and regulatory relationships.

There are also upside monitoring items. The credit direction could improve if raw milk ASP stabilises, sales volume increases, Cash EBITDA is maintained, net gearing declines, the Shengmu transaction completes without excessive debt increase, and the high-value-added mix such as organic milk and A2 milk improves. In particular, it is important to see whether raw milk prices have bottomed, fair value losses on dairy cows normalise, and operating cash flow continues to exceed finance costs and maintenance investment by a sufficient margin.

11. Credit View and Monitoring Focus

At present, CNMDHL has the external profile of an issuer whose 2030 bond was assigned an S&P expected BBB issue rating at issuance, but this report has not reviewed the latest issuer rating or bond rating text. As an internal credit view, the company should be seen as a credit under significant pressure from the raw milk cycle, but supported by Cash EBITDA, operating cash flow, the Mengniu relationship, and funding access, and not immediately in a high-stress situation. The direction of credit quality is broadly stable to slightly weaker in the near term, and rapid credit deterioration is not the base case because Cash EBITDA and operating cash flow remain. However, the possibility that the level or direction of credit quality could change over a relatively short period cannot be ignored if further raw milk price declines, Shengmu transaction funding, changes in the Mengniu relationship, and refinancing deterioration overlap.

The basis for this view is that the company maintained cash earnings capacity despite reporting an accounting loss in 2025. Cash EBITDA was RMB3.063bn, and operating cash flow was also positive. The raw milk business gross margin was maintained at 31.2%, and unit cost and feed cost declined. Mengniu offtake and the major customer relationship also support sales volume and collection. These are the defensive lines that prevent weak raw milk prices from immediately translating into credit stress.

The constraints are clear. The RMB3.108bn fair value loss on dairy cows affected not only accounting losses but also equity and net gearing. Net gearing rose to 115.7%, and current interest-bearing borrowings also increased. The 2030 U.S. dollar bonds extended the maturity profile to the medium term, but increased finance costs and foreign-currency risk. No explicit subsidiary guarantee has been identified for the unsecured Cayman issuer bonds, and the fact that operating cash flow is mainly located in Chinese subsidiaries also constrains recovery under stress.

Therefore, the monitoring priorities in this report are, first, raw milk ASP and Cash EBITDA; second, net gearing and short-term debt; third, Shengmu transaction completion, offer results, and funding arrangements; fourth, Mengniu offtake and related financing facilities; and fifth, ratings, bond prices, and refinancing conditions. In particular, the 2026 interim results should be checked to see whether raw milk ASP is stabilising around the 2025 average, whether sales volume growth is continuing, whether there are signs of fair value losses on dairy cows narrowing, and whether Cash EBITDA and operating cash flow are sufficiently above finance costs.

Report update triggers are the publication of Shengmu SPA Completion and offer results, 2026 interim results, rating actions by S&P and others, a significant price movement in the 2030 bonds, material announcements on the Mengniu offtake agreement or related financing facilities, and a sharp decline or clear recovery in raw milk prices. At present, CNMDHL does not need to be viewed as excessively weak solely because of its accounting loss, but it is also too early to assume stability before a recovery in the raw milk market is confirmed.

12. Short Summary & Conclusion

China Modern Dairy Holdings is a major Chinese raw milk producer, with credit quality supported by its long-term offtake with Mengniu and cost management in large-scale dairy farming. In 2025, the company maintained Cash EBITDA and operating cash flow, while weak raw milk prices and fair value losses on dairy cows led to continued accounting losses and higher net gearing. The 2030 U.S. dollar bonds are unsecured and unsubordinated obligations of the issuer, but no subsidiary guarantee has been identified, and the post-completion funding burden of the Shengmu transaction is the next key item to confirm.

Pending Items

• The latest S&P issuer rating, current rating on the 2030 bonds, rating outlook, and rating triggers have not been confirmed.
• Secondary-market price, spread, and liquidity of the 2030 bonds have not been confirmed.
• Shengmu transaction SPA Completion, Composite Document, mandatory offer results, and post-completion pro forma leverage have not been confirmed.
• Raw milk ASP, Cash EBITDA, operating cash flow, and normalisation of fair value losses on dairy cows in the 2026 interim results are items for the next review.
• Renewal terms for the Mengniu offtake agreement beyond 2028 have not been confirmed.

Sources

• China Modern Dairy Holdings Ltd., Announcement of Final Results for the year ended 31 December 2025, HKEX, 2026-03-24.
• China Modern Dairy Holdings Ltd., U.S.$350,000,000 4.875 per cent. Sustainability Bonds due 2030 Offering Circular, HKEX, 2025-07-11.
• China Modern Dairy Holdings Ltd. and China Shengmu Organic Milk Limited, Joint announcement on satisfaction of a condition precedent under the SPA, HKEX, 2026-05-07.
• China Modern Dairy Holdings Ltd., Major and connected transaction circular in relation to China Shengmu Organic Milk Limited, HKEX, 2025-12-24.
• HKEXnews, Listed Company Information Title Search: China Modern Dairy Holdings Ltd., accessed 2026-05-15.